Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Seagen Inc.
National Institutes of Health Clinical Center (CC)
University of Colorado, Denver
City of Hope Medical Center
Novartis
Var2 Pharmaceuticals
UNC Lineberger Comprehensive Cancer Center
A2 Biotherapeutics Inc.
ModeX Therapeutics, An OPKO Health Company
Columbia University
Rutgers, The State University of New Jersey
Massachusetts General Hospital
Washington University School of Medicine
Corvus Pharmaceuticals, Inc.
Klus Pharma Inc.
Eastern Cooperative Oncology Group
Institut de Cancérologie de Lorraine
Abramson Cancer Center at Penn Medicine
MacroGenics
Institut Bergonié
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
National Cancer Institute (NCI)
University Hospital Tuebingen
Stanford University
Instituto do Cancer do Estado de São Paulo
Novartis
Stanford University
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Siemens Molecular Imaging
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
Roger Williams Medical Center
Case Comprehensive Cancer Center
Light Sciences LLC